Megna, Matteo http://orcid.org/0000-0003-1803-2046
Patruno, Cataldo
Bongiorno, Maria Rita
Gambardella, Alessio
Guarneri, Claudio
Romita, Paolo
Raimondo, Annunziata
Loconsole, Francesco
Fabbrocini, Gabriella
Funding for this research was provided by:
Università degli Studi di Napoli Federico II
Article History
Accepted: 8 May 2022
First Online: 28 May 2022
Declarations
:
: Open access funding provided by Università degli Studi di Napoli Federico II within the CRUI-CARE Agreement.
: Matteo Megna has acted as a speaker or consultant for Abbvie, Amgen, Eli Lilly, Leo Pharma, Janssen, Novartis, and UCB. Gabriella Fabbrocini has acted as a speaker or consultant for Abbvie, Almirall, Amgen, Eli Lilly, Leo Pharma, Janssen, Novartis, Sanofi, and UCB. Cataldo Patruno has acted as an advisor, consultant, speaker, and/or investigator for AbbVie, Amgen, Eli Lilly, Leo Pharma, Novartis, Pfizer, Pierre Fabre, and Sanofi. Claudio Guarneri has received consultation fees and/or grants for research projects and advisory panels and for giving educational lectures from Wyeth-Pfizer, Abbott Immunology-Abbvie, Janssen-Cilag, Novartis, LEO-Pharma, Ely-Lilly, Celgene, Merck-Serono, Sanofi-Aventis, Amgen, and Almirall. The other authors declare no conflicts of interest.
: All procedures related to this work adhered to the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, and its amendments. This study received approval from the local ethics committee or institutional review board at each participating institution.
: Informed consent was obtained from the patients at the time of being prescribed secukinumab. Additional consent for participation in the study was not required and only anonymized data were used in the analysis.
: Not applicable.
: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors made a significant contribution to the work reported, whether in the conception, study design, execution, acquisition of data, analysis, and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.